Bending the Curve: Interview with Edwards Lifesciences

The Planetary Health First Mars Next podcast touched down at The MedTech Conference 2024 in Toronto, Canada, which boasted 4,350 attendees and over 550 sessions and speakers. Orthogonal and PHFMN’s podcast series features insights from executives representing 17 groundbreaking companies at the frontlines of #MedTech Innovation.

Host Michael Mann, MHA and Orthogonal’s Chief Solutions Officer Randy Horton interviewed Donald E Bobo Jr , CVP, Strategy and Corporate Development at Edwards Lifesciences , about how the company partners with stakeholders to bend the curve for patients with cardiovascular disease:?

• One of Edwards’ most exciting recent innovations is EVOQUE, the first transcatheter tricuspid valve replacement for patients with tricuspid regurgitation (TR). Don notes that prior to EVOQUE, there was no cure for TR, leading to many patients with tricuspid regurgitation being overlooked in the healthcare system. Teams at Edwards are helping physicians find those patients again to offer them this new therapy.?
• Software is not one of Edwards’ core competencies, but Donald notes that the company has important data-driven initiatives to gain insights into patient journeys through the healthcare system. Learning from that data enables Edwards to become a better partner to physicians and hospitals.?
• Edwards has seen success with a patient-focused innovation strategy that aligns the interests of various stakeholders, including regulators, payors, hospitals and physicians.?

Looking for a MedTech developer who's AI-ready? Orthogonal has operated on the leading edge of medical device software development for over 15 years, helping companies navigate AI-enhanced connected medical devices and Software as a Medical Device (SaMD) through FDA clearance and onto the market. Schedule your call now: https://orthogonal.io/contact-orthogonal/